1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
Griffiths, K.; Dolezal, O.; Parisi, K.; Angerosa, J.; Dogovski, C.; Barraclough, M.; Sanalla, A.; Casey, J.; González, I.; Perugini, M.;
et al. Shark variable new antigen receptor (VNAR) single domain antibody fragments: Stability and diagnostic applications.
Antibodies 2013, 2, 66–81. [CrossRef]
Liu, J.L.; Anderson, G.P.; Delehanty, J.B.; Baumann, R.; Hayhurst, A.; Goldman, E.R. Selection of cholera toxin specific IgNAR
single-domain antibodies from a naive shark library. Mol. Immunol. 2007, 44, 1775–1783. [CrossRef] [PubMed]
Wesolowski, J.; Alzogaray, V.; Reyelt, J.; Unger, M.; Juarez, K.; Urrutia, M.; Cauerhff, A.; Danquah, W.; Rissiek, B.; Scheuplein,
F.; et al. Single domain antibodies: Promising experimental and therapeutic tools in infection and immunity. Med. Microbiol.
Immunol. 2009, 198, 157–174. [CrossRef] [PubMed]
Feng, M.; Bian, H.; Wu, X.; Fu, T.; Fu, Y.; Hong, J.; Fleming, B.D.; Flajnik, M.F.; Ho, M. Construction and next-generation
sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naïve nurse sharks. Antib. Ther.
2019, 2, 1–11. [CrossRef]
Barelle, C.; Gill, D.S.; Charlton, K. Shark novel antigen receptors—The next generation of biologic therapeutics? Adv. Exp. Med.
Biol. 2009, 655, 49–62. [CrossRef]
Cheong, W.S.; Leow, C.Y.; Abdul Majeed, A.B.A.; Leow, C.H. Diagnostic and therapeutic potential of shark variable new antigen
receptor (VNAR) single domain antibody. Int. J. Biol. Macromol. 2020, 147, 369–375. [CrossRef]
Zielonka, S.; Weber, N.; Becker, S.; Doerner, A.; Christmann, A.; Christmann, C.; Uth, C.; Fritz, J.; Schäfer, E.; Steinmann, B.;
et al. Shark Attack: High affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
J. Biotechnol. 2014, 191, 236–245. [CrossRef]
Zielonka, S.; Empting, M.; Grzeschik, J.; Könning, D.; Barelle, C.J.; Kolmar, H. Structural insights and biomedical potential of
IgNAR scaffolds from sharks. mAbs 2015, 7, 15–25. Available online: http://www.ncbi.nlm.nih.gov/pubmed/25523873 (accessed
on 29 September 2023). [CrossRef]
Cabanillas-Bernal, O.; Dueñas, S.; Ayala-Avila, M.; Rucavado, A.; Escalante, T.; Licea-Navarro, A.F. Synthetic libraries of shark
vNAR domains with different cysteine numbers within the CDR3. PLoS ONE 2019, 14, e0213394. [CrossRef]
Dooley, H.; Flajnik, M.F.; Porter, A.J. Selection and characterization of naturally occurring single-domain (IgNAR) antibody
fragments from immunized sharks by phage display. Mol. Immunol. 2003, 40, 25–33. [CrossRef]
Turner, K.B.; Naciri, J.; Liu, J.L.; Anderson, G.P.; Goldman, E.R.; Zabetakis, D. Next-generation sequencing of a single domain
antibody repertoire reveals quality of phage display selected candidates. PLoS ONE 2016, 11, e0149393. [CrossRef] [PubMed]
Ljungars, A.; Svensson, C.; Carlsson, A.; Birgersson, E.; Tornberg, U.C.; Frendéus, B.; Ohlin, M.; Mattsson, M. Deep mining of
complex antibody phage pools generated by cell panning enables discovery of rare antibodies binding new targets and epitopes.
Front. Pharmacol. 2019, 10, 847. [CrossRef] [PubMed]
Mar. Drugs 2023, 21, 550
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
15 of 16
Rahbarnia, L.; Farajnia, S.; Babaei, H.; Majidi, J.; Veisi, K.; Ahmadzadeh, V.; Akbari, B. Evolution of phage display technology:
From discovery to application. J. Drug Target. 2017, 25, 216–224. [CrossRef] [PubMed]
Pershad, K.; Kay, B.K. Generating thermal stable variants of protein domains through phage display. Methods 2013, 60, 38–45.
[CrossRef] [PubMed]
Igawa, T.; Ishii, S.; Tachibana, T.; Maeda, A.; Higuchi, Y.; Shimaoka, S.; Moriyama, C.; Watanabe, T.; Takubo, R.; Doi, Y.; et al.
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat. Biotechnol.
2010, 28, 1203–1207. [CrossRef]
Luciani, F.; Bull, R.A.; Lloyd, A.R. Next generation deep sequencing and vaccine design: Today and tomorrow. Trends Biotechnol.
2012, 30, 443–452. [CrossRef]
Zeidel, J.D.; Mathai, J.C.; Campbell, J.D.; Ruiz, W.G.; Apodaca, G.L.; Riordan, J.; Zeidel, M.L. Selective permeability barrier to
urea in shark rectal gland. Am. J. Physiol. Ren. Physiol. 2005, 289, 83–89. [CrossRef]
Nagai, T.; Ibata, K.; Park, E.S.; Kubota, M.; Mikoshiba, K.; Miyawaki, A. A variant of yellow fluorescent protein with fast and
efficient maturation for cell-biological applications. Nat. Biotechnol. 2002, 20, 87–90. [CrossRef]
Compagno, L.J.V.; Stevens, J.D. Hemitriakis falcata n.sp. and H. abdita n.sp., two new houndsharks (Carcharhiniformes: Triakidae)
from Australia. Rec. Aust. Mus. 1993, 45, 195–220. [CrossRef]
Honda, Y.; Kondo, H.; Caipang, C.M.; Hirono, I.; Aoki, T. cDNA cloning of the immunoglobulin heavy chain genes in banded
houndshark Triakis scyllium. Fish Shellfish Immunol. 2010, 29, 854–861. [CrossRef]
Ohtani, M.; Hikima, J.; Jung, T.S.; Kondo, H.; Hirono, I.; Aoki, T. Construction of an artificially randomized IgNAR phage display
library: Screening of variable regions that bind to hen egg white lysozyme. Mar. Biotechnol. 2013, 15, 56–62. [CrossRef] [PubMed]
Ohtani, M.; Hikima, J.; Jung, T.S.; Kondo, H.; Hirono, I.; Takeyama, H.; Aoki, T. Variable domain antibodies specific for viral
hemorrhagic septicemia virus (VHSV) selected from a randomized IgNAR phage display library. Fish Shellfish Immunol. 2013, 34,
724–728. [CrossRef] [PubMed]
Kim, W.S.; Chae, H.D.; Jung, I.; Lee, W.K.; Lee, W.J.; Lee, J.; Gong, Y.; Lee, D.; Kim, B.W.; Kim, J.K.; et al. Isolation and
characterization of single domain antibodies from banded houndshark (Triakis scyllium) targeting SARS-CoV-2 spike RBD protein.
Fish Shellfish Immunol. 2023, 138, 108807. [CrossRef]
Takeda, H.; Ozawa, T.; Zenke, H.; Ohnuki, Y.; Umeda, Y.; Zhou, W.; Tomoda, H.; Takechi, A.; Narita, K.; Shimizu, T.; et al. VNAR
development through antigen immunization of Japanese topeshark (Hemitriakis japanica). Front. Bioeng. Biotechnol. 2023, 11,
1265582. [CrossRef]
O’Connell, M.A.; Belanger, B.A.; Haaland, P.D. Calibration and assay development using the four-parameter logistic model. Intell.
Lab. Syst. 1993, 20, 97–114. [CrossRef]
Kim, D.Y.; To, R.; Kandalaft, H.; Ding, W.; van Faassen, H.; Luo, Y.; Schrag, J.D.; St-Amant, N.; Hefford, M.; Hirama, T.; et al.
Antibody light chain variable domains and their biophysically improved versions for human immunotherapy. mAbs 2014, 6,
219–235. [CrossRef]
Joshi, V.; Shivach, T.; Yadav, N.; Rathore, A.S. Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal
antibody therapeutics. Anal. Chem. 2014, 86, 11606–11613. [CrossRef]
Brader, M.L.; Estey, T.; Bai, S.; Alston, R.W.; Lucas, K.K.; Lantz, S.; Landsman, P.; Maloney, K.M. Examination of thermal unfolding
and aggregation profiles of a series of developable therapeutic monoclonal antibodies. Mol. Pharm. 2015, 12, 1005–1017. [CrossRef]
Navratilova, I.; Papalia, G.A.; Rich, R.L.; Bedinger, D.; Brophy, S.; Condon, B.; Deng, T.; Emerick, A.W.; Guan, H.W.; Hayden, T.;
et al. Thermodynamic benchmark study using Biacore technology. Anal. Biochem. 2007, 364, 67–77. [CrossRef]
Prévost, J.; Richard, J.; Gasser, R.; Ding, S.; Fage, C.; Anand, S.P.; Adam, D.; Gupta Vergara, N.G.; Tauzin, A.; Benlarbi, M.;
et al. Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. J. Biol. Chem. 2021, 297, 101151.
[CrossRef]
Leonard, P.; Hayes, C.J.; O’Kennedy, R. Rapid temperature-dependent antibody ranking using Biacore A100. Anal. Biochem. 2011,
409, 290–292. [CrossRef]
Ferreira, L.A.; Povarova, O.I.; Stepanenko, O.V.; Sulatskaya, A.I.; Madeira, P.P.; Kuznetsova, I.M.; Turoverov, K.K.; Zaslavsky, B.Y.
Effects of low urea concentrations on protein-water interactions. J. Biomol. Struct. Dyn. 2017, 35, 207–218. [CrossRef] [PubMed]
Bata, J.E.; Gyenes, L.; Sehon, A.H. The effect of urea of antibody-antigen reactions. Immunochemistry 1964, 1, 289–293. [CrossRef]
[PubMed]
Feige, M.J.; Gräwert, M.A.; Marcinowski, M.; Hennig, J.; Behnke, J.; Ausländer, D.; Herold, E.M.; Peschek, J.; Castro, C.D.; Flajnik,
M.; et al. The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins. Proc. Natl. Acad.
Sci. USA 2014, 111, 8155–8160. [CrossRef] [PubMed]
Curtis, R.A.; Prausnitz, J.M.; Blanch, H.W. Protein-protein and protein–salt interactions in aqueous protein solutions containing
concentrated electrolytes. Biotechnol. Bioeng. 1998, 57, 11–21. [CrossRef]
Valente, J.J.; Verma, K.S.; Manning, M.C.; Wilson, W.W.; Henry, C.S. Second virial coefficient studies of cosolvent-induced protein
self-interaction. Biophys. J. 2005, 89, 4211–4218. [CrossRef]
Jung, S.; Honegger, A.; Plückthun, A. Selection for improved protein stability by phage display. J. Mol. Biol. 1999, 294, 163–180.
[CrossRef]
Bemporad, F.; Taddei, N.; Stefani, M.; Chiti, F. Assessing the role of aromatic residues in the amyloid aggregation of human
muscle acylphosphatase. Protein Sci. 2006, 15, 862–870. [CrossRef]
Mar. Drugs 2023, 21, 550
39.
40.
41.
42.
43.
16 of 16
Fellouse, F.A.; Wiesmann, C.; Sidhu, S.S. Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in
antigen recognition. Proc. Natl. Acad. Sci. USA 2004, 101, 12467–12472. [CrossRef]
Ito, W.; Iba, Y.; Kurosawa, Y. Effects of substitutions of closely related amino acids at the contact surface in an antigen-antibody
complex on thermodynamic parameters. J. Biol. Chem. 1993, 268, 16639–16647. [CrossRef]
Tzang, B.S.; Tsay, G.J.; Lee, Y.J.; Li, C.; Sun, Y.S.; Hsu, T.C. The association of VP1 unique region protein in acute parvovirus B19
infection and anti-phospholipid antibody production. Clin. Chim. Acta 2007, 378, 59–65. [CrossRef] [PubMed]
Katoh, K.; Rozewicki, J.; Yamada, K.D. MAFFT online service: Multiple sequence alignment, interactive sequence choice and
visualization. Brief. Bioinform. 2019, 20, 1160–1166. [CrossRef] [PubMed]
Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.;
Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947–2948. [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...
論文の公開元へ
